The United Bio-Technology (Hengqin) Co., Ltd. clinical trials
A subsidiary of The United Laboratories International Holdings Limited
The registry lists 12 studies whose lead sponsor is The United Bio-Technology (Hengqin) Co., Ltd.. 10 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 14, 2026.
Registry sponsor names on this page
- The United Bio-Technology (Hengqin) Co., Ltd.12 studies
Something wrong with this grouping? Tell us on the The United Laboratories International Holdings Limited page.
Studies
Recruiting first, then most recently updated. Showing 12 of 12. All The United Laboratories International Holdings Limited studies →
- Study of UBT37034 InjectionNot yet recruitingNCT07873645Phase 1
Sponsor listed in the registry: The United Bio-Technology (Hengqin) Co., Ltd.
- Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Diet and Exercise Alone(UNIGUIDE-1)RecruitingNCT07659574Phase 3
Sponsor listed in the registry: The United Bio-Technology (Hengqin) Co., Ltd.
- A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Subcutaneous UBT38006 Injection in Healthy Adult MalesRecruitingNCT07630233Phase 1
Sponsor listed in the registry: The United Bio-Technology (Hengqin) Co., Ltd.
- Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2)RecruitingNCT07653477Phase 3
Sponsor listed in the registry: The United Bio-Technology (Hengqin) Co., Ltd.
- UBT251 Injection Phase Ⅲ Study (OSA-PAP)Not yet recruitingNCT07806851Phase 3
Sponsor listed in the registry: The United Bio-Technology (Hengqin) Co., Ltd.
- UBT251 Injection Phase Ⅲ Study (OSA-NPAP)Not yet recruitingNCT07767942Phase 3
Sponsor listed in the registry: The United Bio-Technology (Hengqin) Co., Ltd.
- Phase I Drug-Drug Interaction Study of UBT251 Injection in Participants With Overweight or ObesityRecruitingNCT07785934Phase 1
Sponsor listed in the registry: The United Bio-Technology (Hengqin) Co., Ltd.
- UBT251 Injection Phase Ⅲ Study (Overweight or Obesity)Not yet recruitingNCT07648225Phase 3
Sponsor listed in the registry: The United Bio-Technology (Hengqin) Co., Ltd.
- UBT251 Injection Phase II Clinical Study (CKD)RecruitingNCT07134335Phase 2
Sponsor listed in the registry: The United Bio-Technology (Hengqin) Co., Ltd.
- A Study of UBT251 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)RecruitingNCT07145151Phase 2
Sponsor listed in the registry: The United Bio-Technology (Hengqin) Co., Ltd.
- UBT251 Injection Phase II Study (Overweight or Obesity)CompletedNCT07177469Phase 2
Sponsor listed in the registry: The United Bio-Technology (Hengqin) Co., Ltd.
- UBT251 Injection Phase II (Type 2 Diabetes Mellitus) StudyCompletedNCT07163624Phase 2
Sponsor listed in the registry: The United Bio-Technology (Hengqin) Co., Ltd.